Inhibitory Effect of Multimodal Nanoassemblies against Glycative and Oxidative Stress in Cancer and Glycation Animal Models

Figure 2

(a) Lowering of the carbonyl content level in the presence of PFT-HSA-TFT-Cy7 and PFT-Hcy-HSA-Cy7 in the lung cancer and glycation animal model. (b) Lowering of MDA content level in the presence of PFT-HSA-TFT-Cy7 and PFT-Hcy-HSA-Cy7 in the lung cancer and glycation animal model. value is <0.05.

(a)

(b)